MM-ABSCH

About the Nagoya Protocol

What is the Nagoya Protocol about? The protocol provides a mechanism for users of genetic resources and provider countries and communities within those countries, to share the benefits of research on genetic resources. In the past, biopiracy was a global problem, especially in developing countries, but under the Protocol genetic research is subject to a contractual agreement.

How is the Protocol implemented? A user (e.g., a pharmaceutical company) must have applied to Government with their proposal and then obtained consent to gather genetic materials (called PIC = Prior Informed Consent) and negotiated terms by which benefits will be shared with the Myanmar and/or the community that provided access (called MAT = Mutually Agreed Terms). Together these elements form an ‘ABS Agreement’.

What types of research are subject to an ABS Agreement? The Protocol applies to any genetic research, including on derivatives, conducted in Myanmar or by foreigners exporting materials, notably under the pharmaceutical, biotechnology, and agriculture sciences.

• The ABS portal on the CBD website
• Key developments related to the ABS Clearing-House
• Relevant decisions and documents on the ABS Clearing-House
• Text of the Nagoya Protocol and courtesy translations
• How to become a Party: States and regional economic integration organizations that are Parties to the Convention on Biological Diversity are eligible to become a Party to the Nagoya Protocol. The United Nations Secretary-General acts as depository for the Nagoya Protocol through the United Nations Treaty Section in New York.
• Information on the current membership of the COP-MOP Bureau
• Nagoya Protocol COP-MOP Decisions